Portfolio company
Abalos Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Theolytics
The company develops oncolytic viral immunotherapies for patients with solid tumours.
Stratosvir
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
Oncorus
This company develops intravenous self-amplifying RNA medicines and viral immunotherapies for patients with solid tumours.
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Tacalyx
This company develops antibody-based therapeutics targeting tumour associated carbohydrate antigens for the treatment of solid tumours in cancer patients.
Abologix
The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.
Asgard Therapeutics
The company develops gene therapies that reprogramme cancer cells into immune cells for patients with various types of tumours.
Bioarchitech
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.